Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diarrhoea-causing enteric protist species in intensively and extensively raised pigs (Sus scrofa domesticus) in Southern Spain. Part I: Prevalence and genetic diversity.
Dashti A, Rivero-Juárez A, Santín M, George NS, Köster PC, López-López P, Risalde MA, García-Bocanegra I, Gómez-Villamandos JC, Caballero-Gómez J, Frías M, Bailo B, Ortega S, Muadica AS, Calero-Bernal R, González-Barrio D, Rivero A, Briz V, Carmena D. Dashti A, et al. Transbound Emerg Dis. 2022 Jul;69(4):e1051-e1064. doi: 10.1111/tbed.14388. Epub 2021 Nov 24. Transbound Emerg Dis. 2022. PMID: 34755463
Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients.
Rivero-Juárez A, Mira JA, Pérez-Camacho I, Macías J, Camacho A, Neukam K, Torre-Cisneros J, Merchante N, Pineda JA, Rivero A; Viral Hepatitis Study Group, part of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI) (Andalusian Society for Infectious Diseases). Rivero-Juárez A, et al. J Antimicrob Chemother. 2011 Jun;66(6):1351-3. doi: 10.1093/jac/dkr091. Epub 2011 Mar 17. J Antimicrob Chemother. 2011. PMID: 21415037
Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4.
Rivero-Juárez A, Camacho Espejo A, Perez-Camacho I, Neukam K, Caruz A, Mira JA, Mesa P, García-Lázaro M, Torre-Cisneros J, Pineda JA, Rivero A. Rivero-Juárez A, et al. J Antimicrob Chemother. 2012 Jan;67(1):202-5. doi: 10.1093/jac/dkr439. Epub 2011 Oct 11. J Antimicrob Chemother. 2012. PMID: 21990051
Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.
Rivero-Juárez A, Camacho A, Merchante N, Pérez-Camacho I, Macias J, Ortiz-Garcia C, Cifuentes C, Torre-Cisneros J, Peña J, Pineda JA, Rivero A; Grupo para el estudio de las hepatitis vı´ricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Rivero-Juárez A, et al. PLoS One. 2013 Jul 18;8(7):e68953. doi: 10.1371/journal.pone.0068953. Print 2013. PLoS One. 2013. PMID: 23874824 Free PMC article.
A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.
Rivero-Juarez A, López-Cortés LF, Camacho A, Mira JA, Téllez F, Marquez M, Merino D, Pineda JA, Rivero A; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR), part of the Sociedad Andaluza de Enfermedades Infecciosas. Rivero-Juarez A, et al. Clin Infect Dis. 2014 Jan;58(1):130-3. doi: 10.1093/cid/cit653. Epub 2013 Sep 24. Clin Infect Dis. 2014. PMID: 24065317
Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.
Rivero-Juarez A, Neukam K, Labarga P, Camacho A, Macias J, Barreiro P, Torre-Cisneros J, Pineda JA, Soriano V, Rivero A. Rivero-Juarez A, et al. J Infect. 2014 Apr;68(4):372-7. doi: 10.1016/j.jinf.2013.11.009. Epub 2013 Nov 22. J Infect. 2014. PMID: 24269677
Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV.
Rivero-Juarez A, Lopez-Cortes LF, Girón-Gonzalez JA, Pineda JA, Rivero A; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas. Rivero-Juarez A, et al. Lancet Infect Dis. 2014 Jan;14(1):13-14. doi: 10.1016/S1473-3099(13)70359-1. Lancet Infect Dis. 2014. PMID: 24355031 No abstract available.
204 results